Development line
Using public regional, national and EU public funding, Fase 1 promotes the development, from preclinical research to clinical trials, of new diagnostic and therapeutic agents by researchers, universities, public R&D centres, start-ups, spin-offs and SMEs.
Clinical Trial line
Through its Clinical Research Centre, Fase 1 promotes, supports and coordinates drug trials, carrying out phase I and IIA clinical trials on behalf of third parties, against payment of a fee.
